Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Return on Capital Employed (ROCE) | 18.1% | 18.7% | 22.2% | 20.9% | 25.0% | 24.2% | 24.6% | 27.1% | 27.9% | 26.4% | 29.7% | 37.1% | 41.2% | 45.2% | 55.7% | 48.9% | 43.6% | 45.7% | 45.1% | 46.1% |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Microsoft Corp's last 12-month Return on Capital Employed (ROCE) is 39.8%, based on the financial report for Dec 31, 2024 (Q4 2024). The average annual Return on Capital Employed (ROCE) for IDEXX Laboratories, Inc. have been 43.2% over the past three years, and 44.4% over the past five years.
As of today, IDEXX Laboratories, Inc.'s Return on Capital Employed (ROCE) is 39.8%, which is higher than industry median of (15.5%). It indicates that IDEXX Laboratories, Inc.'s Return on Capital Employed (ROCE) is Good.